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Introduction

Pneumocystis jirovecii pneumonia (PCP) is a major cause of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection (HIV-related PCP) and other conditions associated with immunosuppressive therapy (1). Invasive diagnostic techniques such as bronchoalveolar lavage (BAL) or transbronchial lung biopsy (TBLB) and specific staining of cyst and/or trophozoites are the gold standard for PCP diagnosis. New techniques such as the identification of P. jirovecii DNA by polymerase chain reaction (PCR) from expectorated and induced sputa showed greater sensitivity for PCP diagnosis than conventional his-HIV PCP are different. However, the previous reports failed to show the differences in these serum indicators between HIV-related PCP and non-HIV PCP. Therefore, we compared serum β-D-glucan and KL-6 as well as clinical characteristics in patients with different clinical backgrounds; HIV-related PCP and non-HIV PCP. In addition, the influence of these serum markers on the outcome of PCP was investigated.
Material and Methods
Patients
Results
Patient characteristics
During the study period, 35 episodes of PCP were confirmed in 34 individuals. Nineteen patients presented as HIV-related PCP patients and 16 had other conditions associated with immunosuppression. Of the 19 HIV-infected patients, 13 presented with PCP as the first manifestation of acquired immunodeficiency syndrome (AIDS). One patient had been previously diagnosed with PCP. The underlying diseases in patients with non-HIV PCP were described in
. All patients with non-HIV PCP had been adminis- 
T a b l e 1 . Co mp a r i s o n o f P a t i e n t Ch a r a c t e r i s t i c s b e t we e n HI V-r e l a t e d P CP a n d No n -HI V P CP
) -
Un l e s s o t h e r wi s e i n d i c a t e d , d a t a a r e p r e s e n t e d a s n u mb e r ( %) o r me d i a n ( r a n g e ) NS : No s i g n i f i c a n t , ND: No d a t a * P r e v i o u s P C P : P a t i e n t wh o h a d a P C P i n t h e p a s t * * Du r a t
i o n o f s y mp t o ms p r i o r t o d i a g n o s i s tered immunosuppressive agents, except those with adult Tcell leukemia. PCP was diagnosed by microscopic methods in 17 of the 19 patients with HIV-related PCP and 11 of 16 patients with non-HIV PCP. All of them also had positive results in the PCR assay. Seven patients (2 with HIV-related PCP and 5 with non-HIV PCP) with negative results in the microscopic analyses were diagnosed based on the PCR assay of BAL fluid.
Serum β-D-glucan and KL-6 values on admission
The serum levels of β-D-glucan were significantly higher in patients with HIV and non-HIV PCP than in patients with other infectious lung diseases and the controls (p<0.05) (Fig. 1a) . Serum β-D-glucan levels were significantly higher in patients with HIV PCP than in those with non-HIV PCP.
Serum KL-6 levels were significantly higher in patients with HIV-related PCP than in those with non-HIV PCP and other pulmonary infections (Fig. 1b) . Although the levels of serum KL-6 were significantly higher in non-HIV PCP patients than in the controls, these levels were not significantly different from those of patients with other infectious lung diseases. Considering the conventional cut-off point (10, 11) , the detection rate and false positive rate of β-D-glucan were 100% and 12%, respectively, in the HIV-related PCP patients and 88% and 12% in the non-HIV PCP patients, respectively. The detection rate and false positive rate of KL-6 were 88% and 37%, respectively, in the HIV-related PCP patients, and 66% and 37% in the non-HIV PCP patients, respectively. In cases in whom both β-D-glucan and KL-6 were positive, the detection rate in HIV-related PCP and F i g u r e 1 . S e r u m β -D-g l u c a n ( a ) a n d KL -6 ( b ) l e v e l s i n p a t i e n t s wi t h HI V-r e l a t e d P CP , n o n -HI V P CP , a n
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non-HIV PCP were 88.2% and 55.5%, respectively. The false positive rate in this setting, was 9.6% in both groups.
Correlations between these markers in the sera and laboratory findings were evaluated in all cases (Fig. 2) 
32). There was no significant correlation between the levels of β-D-glucan and KL-6.
Histopathological and immunohistochemical analysis of the TBLB tissues of an HIV case
Histopathological findings revealed eosinophilic foamy exudates in the intra-alveolar spaces, which were characteristic of P. jirovecii infection (Fig. 3A, arrow) ; these exudates also tested positive with the PAS reaction (Fig. 3B, arrow) . Grocott staining clearly revealed black round or crescent P. jirovecii cysts in the identical part with Fig. 3B (Fig. 3C, (Fig. 3D, double arrow) but also within the exudates in a granular or fine vesicular pattern (Fig. 3D, arrow) . 
arrow). Strong positive immune reaction with anti-KL-6 antibody was detected not only on the surface of proliferating type II alveolar epithelial cells
Clinical findings on admission and outcome
To clarify the prognostic factors of PCP at diagnosis, the clinical findings on admission of the survivors and nonsurvivors were compared (Table 2). The mortality was higher in the non-HIV PCP group than in the HIV-related PCP group. On admission, the following parameters were
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Discussion
In the present study, we evaluated the laboratory and BAL findings to compare the clinical features of HIV-related PCP and non-HIV PCP. The main finding of our study is that β-D-glucan is the most reliable adjunctive diagnostic marker for detecting PCP, particularly in HIV-related PCP patients, but the detection rate of β-D-glucan in the diagnosis of non-HIV PCP is inferior to that of HIV PCP. The levels of β-Dglucan on admission have no influence on the prognosis of this disease. Serum KL-6 was a less useful marker because of its low detection rate and high false positive rate in both groups. The LDH level and the proportion of neutrophils in BAL fluid were correlated with oxygenation impairment.
Our data confirmed the observation of previous studies which reported that mortality is influenced by 3 factors present on admission; these factors are severe hypoxia, low serum albumin level, and BAL neutrophilia as well as the need for mechanical ventilation during therapy (14) (15) (16) . Although LDH and pneumothorax are described as prognostic factors in previous reports (17) (18) . The utility of serum β-Dglucan in the adjunct diagnosis of PCP has been proved in several studies (3) (4) (5) (6) . However, these studies have been conducted on a small number of patients. Tasaka et al have reported its usefulness in a large number of patients (8) (19) . This marker was not a predictor of outcome. Serum S-adenosylmethionine is reported to be another marker for PCP (20) , but the role in the outcome of the marker is unknown, which needs further study.
The serum KL-6 level is known to be a sensitive indicator of various interstitial lung diseases and acute lung injuries (11, 21) . Furthermore, the serum KL-6 level is elevated in some infectious lung diseases such as Legionella pneumonia (22) and severe lung tuberculosis (23) . There has been a report describing elevated serum KL-6 levels in a small number of PCP patients (7) . A new finding in the present study is that the serum KL-6 levels seem to correlate with the duration of symptoms prior to the diagnosis; therefore, the KL-6 level was significantly higher in patients with HIVrelated PCP than in those with non-HIV PCP because the clinical progression is more rapid in patients with non-HIV PCP than in those with HIV-related PCP.
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